Brown-Forman Corporation (BF-B) capitalization

Current snapshot

Market Cap
$12.67B
462.9M shares × $27.37 · as of last filing 2026-01-31
Net Worth
$4.08B
Stockholders' equity · 2026-01-31
Enterprise Value
$15.20B
Market cap + debt − cash
Net Debt
$2.53B
Debt $2.92B − Cash $383.0M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-04-30 $16.48B
FY'24 2024-04-30 $22.83B
FY'23 2023-04-30 $31.27B
FY'22 2022-04-30 $32.41B
FY'21 2021-04-30 $36.67B
FY'20 2020-04-30 $29.88B
FY'19 2019-04-30 $25.69B
FY'18 2018-04-30 $27.14B
FY'17 2017-04-30 $23.10B
FY'16 2016-04-30 $49.19B
FY'15 2015-04-30 $38.45B
FY'14 2014-04-30 $19.30B
FY'13 2013-04-30 $15.16B
FY'12 2012-04-30 $18.66B
FY'11 2011-04-30 $15.79B
FY'11 2010-04-30 $8.64B
FY'11 2009-04-30 $7.04B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q3'26 2026-01-31 $12.67B
Q2'26 2025-10-31 $12.87B
Q1'26 2025-07-31 $13.64B
Q4'25 2025-04-30 $16.47B
Q3'25 2025-01-31 $15.61B
Q2'25 2024-10-31 $20.83B
Q1'25 2024-07-31 $21.36B
Q4'24 2024-04-30 $22.61B
Q3'24 2024-01-31 $26.11B
Q2'24 2023-10-31 $26.96B
Q1'24 2023-07-31 $33.92B
Q4'23 2023-04-30 $31.20B
Q3'23 2023-01-31 $31.99B
Q2'23 2022-10-31 $32.68B
Q1'23 2022-07-31 $35.66B
Q4'22 2022-04-30 $32.31B
Q3'22 2022-01-31 $32.40B
Q2'22 2021-10-31 $32.62B
Q1'22 2021-07-31 $34.09B
Q4'21 2021-04-30 $36.52B
Q3'21 2021-01-31 $34.46B
Q2'21 2020-10-31 $33.51B
Q1'21 2020-07-31 $33.31B
Q4'20 2020-04-30 $29.74B
Q3'20 2020-01-31 $32.52B
Q2'20 2019-10-31 $31.48B
Q1'20 2019-07-31 $26.31B
Q4'19 2019-04-30 $25.43B
Q3'19 2019-01-31 $22.68B
Q2'19 2018-10-31 $22.41B
Q1'19 2018-07-31 $25.78B
Q4'18 2018-04-30 $26.96B
Q3'18 2018-01-31 $33.56B
Q2'18 2017-10-31 $27.56B
Q1'18 2017-07-31 $23.86B
Q4'17 2017-04-30 $22.72B
Q3'17 2017-01-31 $22.07B
Q2'17 2016-10-31 $18.09B
Q1'17 2016-07-31 $38.88B
Q4'16 2016-04-30 $47.62B
Q3'16 2016-01-31 $39.60B
Q2'16 2015-10-31 $43.63B
Q1'16 2015-07-31 $45.24B
Q4'15 2015-04-30 $47.08B
Q3'15 2015-01-31 $18.89B
Q2'15 2014-10-31 $19.79B
Q1'15 2014-07-31 $18.63B
Q4'14 2014-04-30 $38.30B
Q3'14 2014-01-31 $16.54B
Q2'14 2013-10-31 $15.71B
Q1'14 2013-07-31 $15.61B
Q4'13 2013-04-30 $15.07B
Q3'13 2013-01-31 $13.91B
Q2'13 2012-10-31 $13.77B
Q1'13 2012-07-31 $20.10B
Q4'12 2012-04-30 $12.27B
Q3'12 2012-01-31 $17.42B
Q2'12 2011-10-31 $16.16B
Q1'12 2011-07-31 $16.10B
Q4'11 2011-04-30 $10.42B
Q3'11 2011-01-31 $9.69B
Q2'11 2010-10-31 $8.91B
Q1'11 2010-07-31 $9.32B
Q4'11 2010-04-30 $8.55B
Q3'11 2010-01-31
Q2'11 2009-10-31
Q1'11 2009-07-31

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (BF-B CIK 0000014693), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

VKTX

VIKING THERAPEUTICS, INC.

DNLI

Denali Therapeutics Inc.

NAVN

NAVAN, INC.